Multitissue insulin resistance despite near-normoglycemic remission in Africans with ketosis-prone diabetes

Diabetes Care

Volumn 31, Issue 12, 2008, Pages 2332-2337

  Choukem, Simeon Pierre ^a,b   Sobngwi, Eugene ^a,b,c   Fetita, Lila Sabrina ^a   Boudou, Philippe ^a,d   De Kerviler, Eric ^a   Boirie, Yves ^e   Hainault, Isabelle ^d   Vexiau, Patrick ^a   Mauvais Jarvis, Franck ^f   Calvo, Fabien ^b   Gautier, Jean Francois ^a,b,d  

^a SAINT LOUIS HOSPITAL   (France)

^b INSERM   (France)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d CENTRE DE RECHERCHE DES CORDELIERS   (France)

^e UNIVERSITÉ CLERMONT AUVERGNE   (France)

^f NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; FATTY ACID; GLUCOSE; INSULIN; METFORMIN; SULFONYLUREA;

ADULT; AFRICA; AGE DETERMINATION; ARTICLE; BODY MASS; BODY SURFACE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTINUOUS INFUSION; CONTROL GROUP; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; DIET RESTRICTION; DIET THERAPY; DISEASE DURATION; DRUG MEGADOSE; DUAL ENERGY X RAY ABSORPTIOMETRY; FATTY ACID BLOOD LEVEL; FEMALE; FRANCE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; HOSPITAL; HUMAN; INSULIN BLOOD LEVEL; INSULIN INFUSION; INSULIN RESISTANCE; KETOSIS PRONE DIABETES; LOW DRUG DOSE; MALE; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PATCH CLAMP; REMISSION; SEX DETERMINATION; TREATMENT DURATION;

ABSORPTIOMETRY, PHOTON; ADIPOSE TISSUE; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC KETOACIDOSIS; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; LIVER; MALE; MIDDLE AGED; MUSCLE, SKELETAL; REMISSION INDUCTION;

EID: 64349090812     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-0914     Document Type: Article

References (26)

1. American Diabetes Association: Standards of medical care in diabetes: 2007. Diabetes Care 30 (Suppl. 1):S4-S41, 2007
2. Kasuga M: Insulin resistance and pancreatic beta cell failure. J Clin Invest 116:1756-1760, 2006
3. Sobngwi E, Mauvais-Jarvis F, Vexiau P, Mbanya JC, Gautier JF: Diabetes in Africans. Part 2: Ketosis-prone atypical diabetes mellitus. DiabeteMetab 28:5-12, 2002
4. Umpierrez GE, Smiley D, Kitabchi AE: Narrative review: ketosis-prone type 2 diabetes mellitus. Ann Intern Med 144:350357, 2006
5. Winter WE, Maclaren NK, Riley WJ, Clarke DW, Kappy MS, Spillar RP: Maturity-onset diabetes of youth in black Americans. N Engl J Med 316:285-291, 1987
6. Banerji MA, Chaiken RL, Huey H, Tuomi T, Norin AJ, Mackay IR, Rowley MJ, Zim- met PZ, Lebovitz HE: GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4: Flatbush diabetes. Diabetes 43: 741-745, 1994
7. Balasubramanyam A, Zern JW, Hyman DJ, Pavlik V: New profiles of diabetic ke- toacidosis: type 1 vs type 2 diabetes and the effect of ethnicity. Arch Intern Med 159:2317-2322, 1999
8. Mauvais-Jarvis F, Sobngwi E, Porcher R, Riveline JP, Kevorkian JP, Vaisse C, Char- pentier G, Guillausseau PJ, Vexiau P, Gau- tier JF: Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance. Diabetes 53:645-653, 2004
9. Sobngwi E, Vexiau P, Levy V, Lepage V, Mauvais-Jarvis F, Leblanc H, Mbanya JC, Gautier JF: Metabolic and immunogenetic prediction of long-term insulin remission in African patients with atypical diabetes. Diabet Med 19:832-835, 2002
10. Umpierrez GE, Casals MM, Gebhart SP, Mixon PS, Clark WS, Phillips LS: Diabetic ketoacidosis in obese African-Americans. Diabetes 44:790-795, 1995
11. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
12. Sobngwi E, Gautier JF: Adult-onset id-iopathic type I or ketosis-prone type II diabetes: evidence to revisit diabetes classification. Diabetologia 45:283-285, 2002
13. Osei K, Cottrell DA, Adenuwon CA, Ezenwaka EC, Akanji AO, O'Dorisio TM: Serum insulin and glucose concentrations in people at risk for type II diabetes: a comparative study of African Americans and Nigerians. Diabetes Care 16:13671375, 1993
14. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223, 1979
15. Boirie Y, Gachon P, Beaufrere B: Splanchnic and whole-body leucine kinetics in young and elderly men. Am J Clin Nutr 65:489-495, 1997
16. Steele R: Influences of glucose loading and of injected insulin on hepatic glucose output. Ann N Y Acad Sci 82:420-430, 1959
17. Abdul-Ghani MA, Jenkinson CP, Richardson DK, Tripathy D, DeFronzo RA: Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic EpidemiologyStudy. Diabetes 55:1430 - 1435, 2006
18. Consoli A: Role of liver in pathophysiol- ogy of NIDDM. Diabetes Care 15:430441, 1992
19. Buthelezi EP, van der Merwe MT, Lön- nroth PN, Gray IP, Crowther NJ: Ethnic differences in responsiveness of adipocyte lipolytic activity to insulin. Obes Res 8:171-178, 2000
20. Groop LC, Bonadonna RC, DelPrato S, Ratheiser K, Zyck K, Ferrannini E, De- Fronzo RA: Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus: evidence for multiple sites of insulin resistance. J Clin Invest 84: 205-213, 1989
21. DeFronzo RA, Bonadonna RC, Ferrannini E: Pathogenesis of NIDDM: a balanced overview. Diabetes Care 15:318-368, 1992
22. Mitrakou A, Kelley D, Veneman T, Jens- sen T, Pangburn T, Reilly J, Gerich J: Contribution of abnormal muscle and liver glucose metabolism to postprandial hy- perglycemia in NIDDM. Diabetes 39: 1381-1390, 1990
23. Weyer C, Bogardus C, Mott DM, Pratley RE: The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes melli- tus. J Clin Invest 104:787-794, 1999
24. Kahn SE: The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 46:3-19, 2003
25. Sobngwi E, Choukem SP, Agbalika F, Blondeau B, Fetita LS, Lebbe C, Thiam D, Cattan P, Larghero J, Foufelle F, Ferre P, Vexiau P, Calvo F, Gautier JF: Ketosis-prone type 2 diabetes mellitus and human herpesvirus 8 infection in sub-Saharan Africans. JAMA 299:27702776, 2008
26. Brunzell JD, Robertson RP, Lerner RL, Hazzard WR, Ensinck JW, Bierman EL, Porte DJ: Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. JClin Endocrinol Metab 42:222-229, 1976